MedEngine Oy

We bridge medical science with business.

[MedEngine Oy @MedEngineAgency]

💎 In this series, we’d like to introduce some of our long-time MedEngine employees. Aino Vesikansa is a Senior Scientific Consultant on the Medical Data Science team.

📰 https://t.co/09xC8ScQC0

#MedEngine #Introduces #TheValueIsInTheLinks

[MedEngine Oy @MedEngineAgency]

Season's Greetings! For us, the biggest news in 2023 was MedEngine joining @VCLSsocial. We hope you share our excitement!

We wish everyone a peaceful holiday season and encourage all to cherish time with loved ones. Here’s to the exciting times ahead! 🥂

https://t.co/Ph0Q4bO5fG

[MedEngine Oy @MedEngineAgency]

✨ As the year is closing, we have the pleasure of welcoming a new talent, as Mareena Hyypiä joins the Scientific Content & Digital Engagement team. Read more below. A warm welcome!

#MedEngine #WarmWelcome #NewHire #NewEmployee #TheValueIsInTheLinks

https://t.co/C4yiOmmSiG

[MedEngine Oy @MedEngineAgency]

6/6: The combination of clinical data with national registry data through a unique personal ID number allows the building of exceptionally rich real-world datasets with extensive follow-up.

Interested in learning more about the Nordic RWE landscape? Contact us: [email protected]

[MedEngine Oy @MedEngineAgency]

1/6: 🏥 Hospital data lakes and quality registries are unmatched sources of clinical #RWD!

#MedEngine #TheValueIsInTheLinks #RealWorldEvidence #Data #NordicCountries

[MedEngine Oy @MedEngineAgency]

5/6: Typically, the data is collected structurally by a healthcare professional during a patient’s visit to the clinic. The most advanced platforms are seamlessly integrated with electronic health records and are able to collect data directly from patients.

[MedEngine Oy @MedEngineAgency]

5/5: 💡 Are you interested in learning more about #RareDisease​s in the #Nordics? Contact us at [email protected]

[MedEngine Oy @MedEngineAgency]

1/5: 🚀 The #Nordic market is an interesting platform to explore for launching #RareDisease treatments.

#MedEngine #RareDiseaseInsights #TheValueIsInTheLinks #TheNordics

[MedEngine Oy @MedEngineAgency]

4/5: 🗃️ High-quality data enables the generation of real-world evidence allowing the introduction of value-based healthcare solutions. The Nordics foster innovation and collaboration, providing an ideal platform for introducing breakthrough therapies in rare diseases.

[MedEngine Oy @MedEngineAgency]

💎 With this new series, we’d like to introduce some of our long-time MedEngine employees. Let’s start with our beloved Heidi Loponen, a Senior Scientific Consultant on the Medical Data Science team.

#MedEngine #Introduces #TheValueIsInTheLinks

https://t.co/LHoe2r7Lg5

[MedEngine Oy @MedEngineAgency]

In the latest episode of #ExpertOpinions, #MedEngine’s Senior Consultant Simone Møller Hede shares her insights on #PAS #studies and explains why the #Nordics provide unique opportunities for such #research.

💡Read more: https://t.co/hi6XBkT5PK

#PASS #TheValueIsInTheLinks

[MedEngine Oy @MedEngineAgency]

7/7: 📚 Read more of our studies: https://t.co/qq8AR9reJM

[MedEngine Oy @MedEngineAgency]

1/7: #InPress: We've published new #data on #asthma!

For 💡highlights and 💎conclusion, see the chain below ⬇️

📄 Original report: https://t.co/R1Ut6QJD8w

#MedEngine #FINASTHMA #Study #TheValueIsInTheLinks

[MedEngine Oy @MedEngineAgency]

6/7: The study was a collaboration by researchers from #MedEngine, University of Gothenburg/Seinäjoki Central Hospital, University of Helsinki, Turku University Hospital, Tampere University Hospital and GSK, and it was initiated and sponsored by GSK.